Crispr Therapeutics shares owned by Richard W. Paul & Associates
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Richard W. Paul & Associates
from 13F filings
Historical chart of Richard W. Paul & Associates investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Richard W. Paul & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Crispr Therapeutics by Richard W. Paul & Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $2.3k | 42 | 54.00 |
2024-03-31 | $2.9k | 42 | 68.17 |
2023-12-31 | $2.6k | 42 | 62.60 |
2023-09-30 | $1.9k | 42 | 45.38 |
2023-06-30 | $2.4k | 42 | 56.14 |
2023-03-31 | $1.9k | 42 | 45.24 |
2022-12-31 | $1.7k | 42 | 40.64 |
More positions owned by Richard W. Paul & Associates
View all positions for Richard W. Paul & Associates